Macquarie Group LTD Ani Pharmaceuticals Inc Transaction History

Macquarie Group LTD

$83.5 Billion
Q3 2025

A detailed history of Macquarie Group LTD transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Macquarie Group LTD holds 291,129 shares of ANIP stock, worth $24.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

291,129

Previous 423,717 31.29%

Holding current value

$24.5 Million

Previous $27.6 Million 3.54%

% of portfolio

0.03%

Previous 0.03%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$63.35 - $98.81 $8.4 Million - $13.1 Million	-132,588 Reduced 31.29%	291,129 $26.7 Million
Q2 2025 Aug 14, 2025	SELL	$57.79 - $72.95 $1.45 Million - $1.83 Million	-25,118 Reduced 5.6%	423,717 $27.6 Million
Q1 2025 May 15, 2025	SELL	$53.93 - $68.36 $6.14 Million - $7.78 Million	-113,768 Reduced 20.22%	448,835 $30 Million
Q4 2024 Feb 14, 2025	BUY	$53.35 - $61.74 $3.79 Million - $4.38 Million	70,956 Added 14.43%	562,603 $31.1 Million
Q3 2024 Nov 14, 2024	BUY	$54.33 - $65.72 $5.63 Million - $6.81 Million	103,570 Added 26.69%	491,647 $29.3 Million

Q2 2024 Aug 09, 2024	BUY	$58.53 - $68.82 $10.2 Million - $12 Million	174,178 Added 81.43%	388,077 $24.7 Million
Q1 2024 May 14, 2024	SELL	$54.2 - $69.69 $876,034 - $1.13 Million	-16,163 Reduced 7.03%	213,899 $14.8 Million
Q4 2023 Feb 14, 2024	BUY	$48.72 - $65.43 $11.2 Million - $15.1 Million	230,062 New	230,062 $12.7 Million
Q4 2018 Feb 15, 2019	SELL	$41.17 - $56.44 $8,234 - $11,288	-200 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$52.95 - $71.34 $10,590 - $14,268	200 New	200 $11,000

Others Institutions Holding ANIP

# of Institutions

283

Shares Held

20.5M

Call Options Held

30.6K

Put Options Held

30.7K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.46B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Ani Pharmaceuticals Inc Transaction History